Prometheus Biosciences
RXDX
$198.98
Share price
0.07%
Change (1 day)
586.14%
Change (1 year)
Categories
Market capitalization of Prometheus Biosciences (RXDX)
Market cap: $9.51 Billion
As of June 2023 Prometheus Biosciences has a market cap of $9.51 Billion. This makes Prometheus Biosciences the world's 1570th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Prometheus Biosciences from 2021 to 2023
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2023 | $9.51 B | 86.04% |
| 2022 | $5.11 B | 232.13% |
| 2021 | $1.53 B |
End of Day market cap according to different sources
On Jun 8th, 2023 the market cap of Prometheus Biosciences was reported to be:
$9.51 Billion
$9.51 Billion
$9.51 Billion
$9.51 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Epizyme EPZM | $0.24 B | -97.40% | 🇺🇸 USA |
 Akebia Therapeutics AKBA | $0.23 B | -97.56% | 🇺🇸 USA |
 Agenus
AGEN | $0.71 B | -92.52% | 🇺🇸 USA |